The group has also received the US drug regulator's nod to market anti-bacterial drug, linezolid BS B2B Bureau | Ahmedabad February 27, 2017 Last Updated at 15:15 IST Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final ... Business Standard, 2 months ago
Zydus Cadila gets USFDA nod to market muscle relaxant in US - Business Standard, 1 month ago
Zydus subsidiary receives USFDA nod to market Tamiflu drug - Business Standard, 2 months ago
3 images for "zydus group"
Zydus Cadila announced that the USFDA has approved the group�s plan to initiate a Phase 2 clinical trial of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis (PBC) of the liver.Money Control, 2 months ago Zydus gets USFDA nod for phase II trials of liver drug Business Standard, 2 months ago Cadila Healthcare gets Form 483 from USFDA; Stock recovers after sharp setback Sify, 1 month ago
Posted by Equitymaster Asian equity markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.35%, while the Hang Seng is down 0.39%. The Nikkei 225 is trading down by 0.20%. The European markets ended Thursday's session in ...Equitymaster.com, 2 days ago
The market is quite sluggish today with investors largely treading cautiously, looking ahead to the US President Donald Trump's speech on Tuesday, which is likely to spell out some elements of his plans to cut taxes. Activity is quite stock specific with ...Sify, 2 months ago
Indian companies have made acquisitions of $1 billion so far in January Outbound acquisitions by Indian companies have seen a surge in the first month of 2017 after a lull for the past three years. There were only $5.3-billion worth outbound deals, against $30.8-billion inbound last year. In the previous two years, the numbers were worse. Outbound deals stood at $5 billion in 2015 and $1.7 billion in 2104. So, when auto ancillary giant Motherson Sumi acquired Finland’s PKC Group for $604 ...Rediff.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!